Hemostemix Inc (HEM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Hemostemix Inc (Hemostemix), formerly Theravitae Inc, is a biotechnology company that develops, manufactures and commercializes proprietary autologous cell therapy for the treatment of ischemic diseases. The companys clinical-stage candidate includes ACP-01, an autologous cell therapy for the treatment of critical limb ischemia. Its ACP-01 is in Phase II clinical trial in Canada, and the US. The companys intellectual property covers synergetic cell precursors and angiogenic cell precursors, bone cell precursors, myocardial cell precursors, and neural cell precursors. It also operates a research, development, and manufacturing facility at Aspire Health Science state-of-the art facilities in Orlando, Florida. Hemostemix is headquartered in Calgary, Alberta, Canada.

Hemostemix Inc (HEM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
Hemostemix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Hemostemix Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Hemostemix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Hemostemix Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Hemostemix Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Hemostemix Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Hemostemix Enters into Agreement with Topstone Research 10
Licensing Agreements 11
Aspire Health Science Enters into Licensing Agreement with Hemostemix 11
Equity Offering 12
Hemostemix Raises USD0.1 Million in Private Placement of Units 12
Hemostemix Raises USD3.8 Million in Private Placement of Units 13
Hemostemix Raises USD0.8 Million in Rights Offering of Units 14
Hemostemix Raises USD1 Million in First Tranche of Private Placement of Units 15
Theravitae Raises USD3.8 Million in Private Placement of Shares 16
TheraVitae Announces Private Placement Of Shares For US$1 Million 17
Debt Offering 18
Hemostemix Raises USD0.37 Million in Private Placement of Debentures 18
Hemostemix Raises USD1.3 Million in Private Placement of Debentures and Notes 19
Acquisition 20
Technical Ventures Acquires TheraVitae in Reverse Takeover Transaction 20
Hemostemix Inc - Key Competitors 21
Hemostemix Inc - Key Employees 22
Hemostemix Inc - Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 24
Corporate Communications 24
Jul 05, 2018: Hemostemix Formalizes World-Class Scientific Advisory Board 24
Jan 25, 2017: Hemostemix Announces Reorganization 26
Jan 06, 2017: Hemostemix Announces Corporate Update 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List Of Tables


Hemostemix Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Hemostemix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Hemostemix Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Hemostemix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Hemostemix Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Hemostemix Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Hemostemix Enters into Agreement with Topstone Research 10
Aspire Health Science Enters into Licensing Agreement with Hemostemix 11
Hemostemix Raises USD0.1 Million in Private Placement of Units 12
Hemostemix Raises USD3.8 Million in Private Placement of Units 13
Hemostemix Raises USD0.8 Million in Rights Offering of Units 14
Hemostemix Raises USD1 Million in First Tranche of Private Placement of Units 15
Theravitae Raises USD3.8 Million in Private Placement of Shares 16
TheraVitae Announces Private Placement Of Shares For US$1 Million 17
Hemostemix Raises USD0.37 Million in Private Placement of Debentures 18
Hemostemix Raises USD1.3 Million in Private Placement of Debentures and Notes 19
Technical Ventures Acquires TheraVitae in Reverse Takeover Transaction 20
Hemostemix Inc, Key Competitors 21
Hemostemix Inc, Key Employees 22
Hemostemix Inc, Subsidiaries 23

List Of Figures


Hemostemix Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Hemostemix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Hemostemix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Hemostemix Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Hemostemix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Hemostemix Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Hemostemix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Hemostemix Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Hemostemix Inc (HEM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Hemostemix Inc (Hemostemix), formerly Theravitae Inc, is a biotechnology company that develops, manufactures and commercializes proprietary autologous cell therapy for the treatment of ischemic diseases. The companys clinical-stage candidate includes

USD 250 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available